Ganesh Raveendran, MD

Assistant Professor of Medicine
Interventional Cardiology
Medical Director, Cardiac Catheterization Laboratory
Administrative Director, Interventional Cardiology
 

A graduate of the University of Minnesota’s general- and interventional-cardiology fellowship programs, Dr. Ganesh Raveendran joined the faculty in 2005 after practicing at the Mayo Clinic in Rochester, Minnesota. In addition to interventional cardiology, Dr. Raveendran is board-certified in critical-care medicine. In March 2010, he became the medical director of the cardiac catheterization laboratory and the administrative director for interventional cardiology.

In 2007, Dr. Raveendran earned a master’s degree in clinical research design and statistical analysis. His current research interests include autologous stem-cell therapy for cardiac repair.

Dr. Raveendran is highly committed to optimizing systems for high-quality patient care, and is a Minnesota leader with the American Heart Association’s nationwide Mission: Lifeline™, program, which seeks to save lives by closing the gaps that separate heart-attack patients from timely access to appropriate treatment.

Dr. Raveendran’s clinical interests include diagnostic and interventional cardiac catheterization in critical-care and other high-risk patients, and minimally-invasive closure of congenital heart defects in adults.

Professional Organizations

American Heart Association, member

• Mission Lifeline™ Steering Committee, Co-Chair (Minnesota-wide STEMI system implementation)

Selected Publications

Wilson RF, Raveendran G. What's good for the gander is now good for the goose. JACC 2008;51:2321-2322

Long KH, Ting HH, McMurtry EK, Lennon RJ, Wood DL, Holmes DR Jr, Raveendran G, Rihal CS. A longitudinal analysis of outcomes associated with abciximab and eptifibatide in a consecutive series of 3,074 percutaneous coronary interventions. Value Health 2008;11:462-469

Raveendran G, Ting HH, Best PJ, Holmes DR Jr, Lennon RJ, Singh M, Bell MR, Long KH, Rihal CS. Eptifibatide vs. abciximab as adjunctive therapy during primary percutaneous coronary intervention for acute myocardial infarction. Mayo Clin Proc 2007;82:196-202

Ting HH, Raveendran G, Lennon RJ, Long KH, Singh M, Wood DL, Gersh BJ, Rihal CS, Holmes DR Jr. A total of 1,007 percutaneous coronary interventions without onsite cardiac surgery: Acute and long-term outcomes. JACC 2006;47:1713-1721

Panetta CJ, Fasseas P, Raveendran G, Garratt KN. Pseudoperforation during kissing-balloon angioplasty. Catheter Cardiovasc Interv 2004;63:290-293